April 01, 2025

GEM Helps Put T2D in Remission

Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.

Conexiant

April 01, 2025

Staff Hiring, Training + Retention: Front-Desk Tasks + Training

Assigning responsibilities and cross-training are key to making the most of your front desk.

Eyecare Business

April 01, 2025

Cracking the Bacterial Vaginosis Resistance Code

Investigators have identified distinct Gardnerella species with varying antibiotic resistance patterns, potentially guiding more effective treatment for recurrent bacterial vaginosis.

Conexiant

April 01, 2025

Cemiplimab Effective for Advanced cSCC

Meta-analysis of 19 studies reveals promising 54.5% objective response rate and manageable safety profile for PD-1 inhibitor in treating advanced cutaneous squamous cell carcinoma.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 31, 2025

Sex Matters: Key Finding in Alzheimer's Disease Progression

"Sex differences in the pathological progression of AD call for sex-specific timing considerations when administrating anti-Aβ and anti-tau treatments."

Conexiant

March 31, 2025

Clopidogrel Outshines Aspirin After PCI

“In our study, clopidogrel beat aspirin as a lifelong maintenance monotherapy after standard-duration dual antiplatelet therapy."

Conexiant

March 31, 2025

Persistent PSA Associated with Survival Risk

PSA level assessed for at least 3 months postoperatively may minimize overtreatment, according to a recent study.

Conexiant